Uncomplicated Plasmodium Falciparum Malaria

• CLINICAL_TRIALS trial_result · 2026-03-13
  Clinical Trial Update: Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria (Cohort B2) [Phase 2]

  This update reports Phase 2 results from a platform trial assessing the efficacy and safety of anti-malarial agents in adults with uncomplic…

• CLINICAL_TRIALS trial_result · 2025-11-18
  Clinical Trial Update: A Trial to Compare the Efficacy, Safety and Tolerability of Combinations of 3 Anti-malarial Drugs Against Combina-tions of 2 Anti-malarial Drugs. [Phase 3]

  A Phase 3 trial sponsored by the University of Oxford comparing three-drug anti-malarial combinations to two-drug regimens for uncomplicated…

• CLINICAL_TRIALS trial_result · 2023-05-16
  Clinical Trial Update: Momordica Charantia and Dihydroartemisinin-piperaquined-primaquine for Uncomplicated Plasmodium Falciparum Malaria Patients in Southwest Sumba Regency [Phase 2]

  A Phase 2 clinical trial evaluating Momordica charantia combined with dihydroartemisinin-piperaquine-primaquine for uncomplicated Plasmodium…

• CLINICAL_TRIALS trial_result · 2022-02-10
  Clinical Trial Update: Efficacy and Safety of KAF156 in Combination With LUM-SDF in Adults and Children With Uncomplicated Plasmodium Falciparum Malaria [Phase 2]

  Phase 2 study evaluating efficacy and safety of KAF156 in combination with LUM-SDF for uncomplicated Plasmodium falciparum malaria in adults…

• CLINICAL_TRIALS trial_result · 2021-11-22
  Clinical Trial Update: Pyronaridine and Artesunate (3:1) in Children With Acute Uncomplicated Plasmodium Falciparum Malaria [Phase 2]

  Phase 2 trial update on pyronaridine-artesunate (3:1) in children with uncomplicated Plasmodium falciparum malaria; results posted after com…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2012-04-27
  Clinical Trial Update: Efficacy, Safety and Tolerability of Co-artemether in Non-immune Travelers [Phase 4]

  Phase 4 trial update evaluating Co-artemether (artemether/lumefantrine) for acute uncomplicated Plasmodium falciparum malaria in non-immune …